Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: results from phase two of the REALIZE study

In phase one of the REALIZE study, zolmitriptan nasal spray demonstrated a significant headache response from 10 min post–dose and total symptom relief from 30 min post–dose. The objective of phase two was to investigate patients' dosing patterns, satisfaction and preference following openlabel...

Descripción completa

Detalles Bibliográficos
Autores principales: Gawel, M., Aschoff, J., May, A., Charlesworth, B. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2005
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452072/
https://www.ncbi.nlm.nih.gov/pubmed/16362714
http://dx.doi.org/10.1007/s10194-005-0237-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452072/
https://www.ncbi.nlm.nih.gov/pubmed/16362714
http://dx.doi.org/10.1007/s10194-005-0237-3

Ejemplares similares